Selected Publications from 2024


Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2
Evans DG, Burghel GJ, Howell SJ, Pugh S, Forde C, Howell A, Lalloo F, Woodward ER
Journal of Medical Genetics   2024  Published Online First: 12 April   doi: 10.1136/jmg-2023-109826
Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: lower rates for 5-years post chemotherapy
Evans DG, Morgan R,D, Crosbie EJ, Howell SJ, Forde C, Howell A, Lalloo F, Woodward ER
Genetics in Medicine   2024    doi: https://
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer
Shi-Yang Li, Jan A Hammarlund, Gang Wu, Jia-Wen Lian, Sacha J Howell, Robert B Clarke, Antony D Adamson, Cátia F Gonçalves, John B Hogenesch, Ron C Anafi, Qing-Jun Meng
Proceedings of the National Academy of Sciences of the United States of America (PNAS)  2024  February 6, 121,(7)
A novel preclinical model of the normal human breast
Wilby, A.J., Cabral, S., Zoghi, N., Howell, S.J., Farnie, G., Harrison, H.
J Mammary Gland Biol Neoplasia   2024  Volume 29, article number 9,


Date:  22 January 202500:00
Speaker:  Mark Clemons & John Hilton
From:  Canada
Title:  TBC
Host:  Sacha Howell